AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
This page offers a quick comparison of Index Fund and Target Date for retirement, with tips on matching your plans and risk tolerance.
24,517 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Nvidia sits at the center of a rapid AI infrastructure buildout. Here’s how the stock could move by 2029, based on gr...
Netflix stock has slipped from its mid-2025 highs, now flirting with a 52-week low. This article explains what that m...
Snap is playing a high-stakes game. This article breaks down snap’s specs gamble, what it would take for AR hardware ...
NVIDIA stock steadies after a summer pullback as analysts largely stay bullish. Here’s a fresh look at the nvidia sto...
Microsoft and Twitter are introducing AI-focused bug bounty programs to surface safety flaws and bias. The move refle...
A softer-than-expected June jobs report revived bets the Fed will pause rate hikes, pushing Bitcoin back above $61,00...
Marvell Technology has bold dreams about joining the trillion-dollar club. This article lays out a practical timeline...
Microsoft is not shrinking its ambitions. In this deep dive, we explore how the tech giant aims to reset its gaming d...
Zillow Group announces Zillow Pro nationwide, a premium tool that reveals real-time consumer activity to agents, help...
Eric Trump’s American Bitcoin announced a 1-for-15 reverse stock split to protect its Nasdaq listing as its treasury ...
A CBS Philadelphia anchor became a reminder that scammers exploit trusted voices. Learn how the philadelphia anchor s...